Hudson Caetano Polonini

Dr. Hudson Caetano Polonini

Fagron BV, Rotterdam, Zuid-Holland, The Netherlands
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
Hudson Caetano PoloniniHudson Caetano Polonini
Hudson Caetano Polonini
LLLarissa Lavorato Lima
Larissa Lavorato Lima
KGKarla Mara Gonçalves
Karla Mara Gonçalves
ACAntônio Márcio Resende Do Carmo
Antônio Márcio Resende Do Carmo
ASAdilson David da Silva
Adilson David da Silva
NRNádia Rezende Barbosa Raposo
Nádia Rezende Barbosa Raposo

Verified
Journal Article
Open access
PDF file
AFAnderson de Oliveira Ferreira
Anderson de Oliveira Ferreira
Hudson Caetano PoloniniHudson Caetano Polonini
Hudson Caetano Polonini
EDEli C. F. Dijkers
Eli C. F. Dijkers
The number of COVID-19 patients is still growing exponentially worldwide due to the high transmissibility of the SARS-CoV-2 virus. Therapeutic agents currently under investigation are antiviral drugs, vaccines, and other adjuvants that could relieve symptoms or improve the healing process. In this review, twelve therapeutic agents that could play a role in prophylaxis or improvement of the COVID-19-associated symptoms (as add-on substances) are discussed. Agents were identified based on their known pharmacologic mechanism of action in viral and/or nonviral fields and are postulated to interact with one or more of the seven known mechanisms associated with the SARS-CoV-2 virus: (i) regulation of the immune system; (ii) virus entrance in the cell; (iii) virus replication; (iv) hyperinflammation; (v) oxidative stress; (vi) thrombosis; and (vii) endotheliitis. Selected agents were immune transfer factor (oligo- and polypeptides from porcine spleen, ultrafiltered at <10 kDa; Imuno TF®), anti-inflammatory natural blend (Uncaria tomentosa, Endopleura uchi and Haematoccocus pluvialis; Miodesin®), zinc, selenium, ascorbic acid, cholecalciferol, ferulic acid, spirulina, N-acetylcysteine, glucosamine sulfate potassium hydrochloride, trans-resveratrol, and maltodextrin-stabilized orthosilicic acid (SiliciuMax®). This review gives the scientific background on the hypothesis that these therapeutic agents can act in synergy in the prevention and improvement of COVID-19-associated symptoms.

1 January 2016 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
AFAnderson O. Ferreira
Anderson O. Ferreira
Hudson Caetano PoloniniHudson Caetano Polonini
Hudson Caetano Polonini
SSSharlene L. Silva
Sharlene L. Silva
FPFernando B. Patrício
Fernando B. Patrício
MBMarcos Antônio F. Brandão
Marcos Antônio F. Brandão
NRNádia R.B. Raposo
Nádia R.B. Raposo

1 September 2012 in Trends in Psychiatry and Psychotherapy
Verified
Journal Article
Open access
PDF file
MTMárcia Helena Fávero de Souza Tostes
Márcia Helena Fávero de Souza Tostes
Hudson Caetano PoloniniHudson Caetano Polonini
Hudson Caetano Polonini
WGWagner Farid Gattaz
Wagner Farid Gattaz
NRNádia Rezende Barbosa Raposo
Nádia Rezende Barbosa Raposo
EBEdilene Bolutari Baptista
Edilene Bolutari Baptista
Objective: To confirm previous evidence suggesting an association between autism and low vitamin D serum levels. Methods: This preliminary exploratory study assessed the circulating levels of 25-hydroxyvitamin D (25-OHD) in pediatric patients with autism and in typically developing controls from Juiz de Fora, Brazil. Results: Serum levels of 25-OHD were lower in children with autism (26.48 ± 3.48 ng mL-1) when compared to typically developing subjects (40.52 ± 3.13 ng mL-1) (p < 0.001). Conclusion: Our findings attest to the importance of vitamin supplementation during pregnancy and in the treatment of children with autism, who tend to present low vitamin D consumption rates.

11 October 2013 in Molecules
Verified
Journal Article
Open access
PDF file
DZDanielle C. Zimmermam-Franco
Danielle C. Zimmermam-Franco
EBEdilene B. Bolutari
Edilene B. Bolutari
Hudson Caetano PoloniniHudson Caetano Polonini
Hudson Caetano Polonini
ACAntônio Márcio R. Do Carmo
Antônio Márcio R. Do Carmo
MCMaria Das Graças A. M. Chaves
Maria Das Graças A. M. Chaves
NRNádia R. B. Raposo
Nádia R. B. Raposo
Dermatophytoses are mycoses that affect keratinized tissues in both humans and animals. The aim of this study was to investigate the antifungal activity of the oleoresin extracted from Copaifera langsdorffii Desf. against the strains Microsporum canis ATCC 32903, Microsporum gypseum ATCC 14683, Trichophyton mentagrophytes ATCC 11481 and Trichophyton rubrum CCT 5507. The antimicrobial activity was determined by minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) values. Ketoconazole and terbinafine were used as reference drugs. The copaiba oleoresin showed moderate fungicidal activity against T. mentagrophytes ATCC 11481 (MIC and MFC = 170 μg mL−1) and weak fungicidal activity against T. rubrum CCT 5507 (MIC = 1,360 μg mL−1 and MFC = 2,720 μg mL−1). There was no activity against M. canis ATCC 32903 and M. gypseum ATCC 14683. SEM analysis revealed physical damage and morphological alterations such as compression and hyphae clustering in the structure of the fungi exposed to the action of the oleoresin. The results stimulate the achievement of in vivo assays to confirm the benefits of the application of oleoresin extracted from copaiba in the treatment of dermatophytosis, both in humans and in animals.

1 September 2012 in Brazilian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
PDF file
RTRaquel da Silva Teixeira
Raquel da Silva Teixeira
PRPaula Rafaela Rocha
Paula Rafaela Rocha
Hudson Caetano PoloniniHudson Caetano Polonini
Hudson Caetano Polonini
MBMarcos Antônio Fernandes Brandão
Marcos Antônio Fernandes Brandão
MCMaria das Graças Afonso Miranda Chaves
Maria das Graças Afonso Miranda Chaves
NRNádia Rezende Barbosa Raposo
Nádia Rezende Barbosa Raposo
In order to treat hyperpigmentation-related problems, there has been a global trend in developing cosmetics claiming to have skin-whitening properties, which act by inhibiting melanin biosynthesis. The objective of this work was to evaluate the in vitro mushroom tyrosinase inhibitory activity of five Amazonian native flora oils, and so to verify the possibility of their incorporation into cosmetic products. In addition, the fatty acid composition of the essential oils was determined by gas chromatography-flame ionisation detection in order to determine the main components of these oils. The tyrosinase inhibitory activity of the tested oils was found to be in the following order: açaí (IA50 = 66.08 µg mL-1) > tucumã > patauá > pracaxi > castanha do Brasil. This study suggests that açaí oil has great potential in the treatment of hyperpigmentation and other related disorders, due to its considerable tyrosinase inhibitory activity.